These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8170550)

  • 21. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ; Alshubaili AF; Santhamoorthy P; Sharafuddin KM
    Med Princ Pract; 2008; 17(5):422-4. PubMed ID: 18685286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: treatment with high-dose intravenous immunoglobulin.
    Vedanarayanan VV; Kandt RS; Lewis DV; DeLong GR
    Neurology; 1991 Jun; 41(6):828-30. PubMed ID: 2046925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful treatment with additional plasmapheresis for the exacerbation of acute neurological symptoms in a girl with multiple sclerosis].
    Mogami Y; Yamada K; Toribe Y; Yanagihara K; Mano T; Suzuki Y
    No To Hattatsu; 2011 Jan; 43(1):36-40. PubMed ID: 21400930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose methotrexate with leucovorin rescue: For monumentally severe CNS inflammatory syndromes.
    Beh SC; Kildebeck E; Narayan R; Desena A; Schell D; Rowe ES; Rowe V; Burns D; Whitworth L; Frohman TC; Greenberg B; Frohman EM
    J Neurol Sci; 2017 Jan; 372():187-195. PubMed ID: 28017209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
    Cortese A; Franciotta D; Alfonsi E; Visigalli N; Zardini E; Diamanti L; Prunetti P; Osera C; Gastaldi M; Berzero G; Pichiecchio A; Piccolo G; Lozza A; Piscosquito G; Salsano E; Ceroni M; Moglia A; Bono G; Pareyson D; Marchioni E
    J Neurol Sci; 2016 Apr; 363():182-7. PubMed ID: 27000248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of plasmapheresis performed in hemodialysis units for the treatment of anti-neutrophilic cytoplasmic antibody-associated systemic vasculitides.
    Aydin Z; Gursu M; Karadag S; Uzun S; Tatli E; Sumnu A; Ozturk S; Kazancioglu R
    Ther Apher Dial; 2011 Oct; 15(5):493-8. PubMed ID: 21974704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
    Trouillas P; Neuschwander P; Nighoghossian N; Adeleine P; Tremisi P
    Rev Neurol (Paris); 1989; 145(5):369-77. PubMed ID: 2662340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit in long-term response and mortality of treatment with intravenous immunoglobulin prior to plasmapheresis in peripheral polyneuropathies.
    Parra-Salinas I; González-Rodríguez VP; Gracia Pina JA; Gimeno Lozano JJ; García-Erce JA
    Transfus Clin Biol; 2017 Feb; 24(1):9-14. PubMed ID: 27865608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective treatment of osmotic demyelination syndrome with plasmapheresis: a case report and review of the literature.
    Wijayabandara M; Appuhamy S; Weerathunga P; Chang T
    J Med Case Rep; 2021 Jan; 15(1):6. PubMed ID: 33430956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
    Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ
    J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting demyelination and virtual hypoxia with high-dose biotin as a treatment for progressive multiple sclerosis.
    Sedel F; Bernard D; Mock DM; Tourbah A
    Neuropharmacology; 2016 Nov; 110(Pt B):644-653. PubMed ID: 26327679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meningeal inflammation and demyelination in a patient clinically diagnosed with acute disseminated encephalomyelitis.
    Koshihara H; Oguchi K; Takei Y; Kitazawa K; Higuchi K; Ohara S
    J Neurol Sci; 2014 Nov; 346(1-2):323-7. PubMed ID: 25216555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)].
    Baba M; Ogawa M; Matsunaga M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1336-7. PubMed ID: 9128399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymptomatic Mycoplasma Infection Causing Acute Demyelinating Encephalomyelitis: Case Report and Review of Literature.
    Dawson E; Singh D; Armstrong C; Maatouk O; Akingbola O; Nelson S
    Clin Pediatr (Phila); 2016 Feb; 55(2):185-8. PubMed ID: 25813385
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasmapheresis in multiple sclerosis: preliminary findings.
    Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
    Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative stress induced by lipid peroxidation is related with inflammation of demyelination and neurodegeneration in multiple sclerosis.
    Wang P; Xie K; Wang C; Bi J
    Eur Neurol; 2014; 72(3-4):249-54. PubMed ID: 25277682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Features and Genetic Risk of Demyelination Following Anti-TNF Treatment.
    Lin S; Green HD; Hendy P; Heerasing NM; Chanchlani N; Hamilton B; Walker GJ; Heap GA; Hobart J; Martin RJ; Coles AJ; Silverberg MS; Irving PM; Chung-Faye G; Silber E; Cummings JRF; Lytvyak E; Andersen V; Wood AR; Tyrrell J; Beaumont RN; Weedon MN; Kennedy NA; Spiers A; Harrower T; Goodhand JR; Ahmad T
    J Crohns Colitis; 2020 Dec; 14(12):1653-1661. PubMed ID: 32497177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of multiple sclerosis associated with chronic inflammatory demyelinating polyradiculoneuropathy].
    Watanabe Y; Ishikawa Y; Wakai S; Tachi N; Chiba S
    No To Hattatsu; 1993 Jan; 25(1):70-5. PubMed ID: 8416699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis.
    Li M; Wang Y; Qiu Q; Wei R; Gao Y; Zhang L; Wang Y; Zhang X; Chen X
    J Clin Apher; 2016 Aug; 31(4):375-80. PubMed ID: 26018932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of therapeutic plasmapheresis for neurological disorders.
    Natl Inst Health Consens Dev Conf Consens Statement; 1986; 6(4):1-7. PubMed ID: 3537747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.